Search For "glenmark"
Glenmark Pharmaceuticals secures its position in the prestigious Dow Jones
Updated : 5 years, 3 months ago IST
Mumbai (Maharashtra) [India], November 26 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that the company has been listed in the Dow Jones Sustainability Index (DJSI), under the category of emerging markets
Read More
Recently published data on Favipiravir as treatment for mild to moderate C
Updated : 5 years, 3 months ago IST
Mumbai (Maharashtra) [India], November 23 (ANI/PRNewswire): The oral antiviral medication Favipiravir, that prevents the replication phase of the virus life-cycle, leads to significant improvement in clinical cure in patients with mild to moderate COVID-19.
Read More
Glenmark Pharmaceuticals receives ANDA approval for Tacrolimus Capsules US
Updated : 5 years, 4 months ago IST
Mumbai (Maharashtra) [India], November 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Tacrolimus Capsules USP, 0.5 mg, 1 mg and 5 mg, the generic version of Prograf®1 C
Read More
Glenmark announces Q2 FY20-21 results
Updated : 5 years, 4 months ago IST
Mumbai (Maharashtra) [India], November 7 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led global integrated pharmaceutical company, today announced its financial results for the second quarter ended Sept 30, 2020.
Read More
Glenmark Pharmaceuticals receives ANDA approval for Sirolimus tablets, 0.5
Updated : 5 years, 4 months ago IST
Mumbai (Maharashtra) [India], Oct 19 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc, USA (Glenmark) has received final approval by the United States Food & Drug Administration (US FDA) for Sirolimus Tablets, 0.5 mg, 1 mg and 2 mg, the generic version of Rapamune®1 Tablets, 0.5 mg, 1
Read More
Glenmark introduces NINDANIB (Nintedanib) and is amongst the first to laun
Updated : 5 years, 5 months ago IST
Mumbai (Maharashtra) [India], October 14 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today launched NINDANIB (Nintedanib 100 and 150 mg capsules) for the treatment of pulmonary fibrosis in India.
Read More
Glenmark Pharmaceuticals receives ANDA approval for Dimethyl Fumarate Dela
Updated : 5 years, 5 months ago IST
Mumbai (Maharashtra) [India] October 7 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc, USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (US FDA) for Dimethyl Fumarate Delayed-Release Capsules, 120 mg and 240 mg, the generic version of Tecfide
Read More
Glenmark appoints Dipankar Bhattacharjee to its Board of Directors
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], Aug 17 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, announced the appointment of Dipankar Bhattacharjee as Independent Non-Executive Director on the Board of the organization for a period of five years wit
Read More
Glenmark's consolidated revenue grew by 0.94 per cent at Rs 23,447.87 mil
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India] Aug 15 (ANI/PRNewswire): Highlights for Q1 FY 2020-21
Read More
Glenmark introduces higher strength (400 mg) of FabiFlu® to reduce th
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India] Aug 6 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, today announced that it will introduce a 400 mg version of oral antiviral FabiFlu®, for the treatment of mild to moderate COVID-19 in India.
Read More
Glenmark introduces higher strength of FabiFlu to reduce pill burden of Co
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], Aug 6 (ANI): Glenmark Pharmaceuticals will introduce a 400 mg version of oral anti-viral FabiFlu for the treatment of mild to moderate Covid-19 in India.
Read More
Glenmark announces top-line results from phase 3 clinical trial of Favipir
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India] July 23 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd - a global research-led pharmaceutical company - announced top-line results from a phase 3 clinical trial in mild to moderate COVID-19 patients, conducted across seven clinical sites in India.
Read More